161 related articles for article (PubMed ID: 37800816)
1. Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT.
Zhang N; Zhang S; Ma L; Qiu L; Meng QL; Cai J; Xu Z; Yao H; Fan FY
Medicine (Baltimore); 2023 Oct; 102(40):e35413. PubMed ID: 37800816
[TBL] [Abstract][Full Text] [Related]
2. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
Li L; Wu C; Chai Y; Dong C; Zhao L
Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613
[TBL] [Abstract][Full Text] [Related]
3. Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine.
Yuan L; Sun L; Bo J; Zhou Y; Li HH; Yu L; Gao CJ
Ann Transplant; 2011; 16(3):135-8. PubMed ID: 21959522
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.
Gibson JF; Alpdogan O; Subtil A; Girardi M; Wilson LD; Roberts K; Foss F
J Am Acad Dermatol; 2015 Jun; 72(6):1010-5.e5. PubMed ID: 25981001
[TBL] [Abstract][Full Text] [Related]
5. Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers.
Shen XZ; Yu SL; Liu F; Luo ZY
Medicine (Baltimore); 2020 Oct; 99(42):e22629. PubMed ID: 33080699
[TBL] [Abstract][Full Text] [Related]
6. Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report.
Dong P; Wang L; Zhu H; Li L
Medicine (Baltimore); 2018 Nov; 97(46):e12980. PubMed ID: 30431571
[TBL] [Abstract][Full Text] [Related]
7. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology and current treatments for the subcutaneous panniculitis-like T cell lymphoma: An updated review.
Lin EC; Liao JB; Fang YH; Hong CH
Asia Pac J Clin Oncol; 2023 Feb; 19(1):27-34. PubMed ID: 35509196
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation.
Jung HR; Yun SY; Choi JH; Bae SH; Ryoo HM; Kum YS
Cancer Res Treat; 2011 Dec; 43(4):255-9. PubMed ID: 22247712
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high-dose chemotherapy (BFM-NHL & ALL-90) and autologous peripheral blood stem cell transplantation.
Sakurai E; Satoh T; Akiko YA; Maesawa C; Tsunoda K; Endo M; Akasaka T; Masuda T
J Clin Exp Hematop; 2013; 53(2):135-40. PubMed ID: 23995110
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature.
Ou W; Zhao Y; Wei A; Ma H; Zhang L; Lian H; Zhang Q; Wang D; Li Z; Wang T; Zhang R
Clin Exp Med; 2023 Dec; 23(8):4575-4583. PubMed ID: 37840116
[TBL] [Abstract][Full Text] [Related]
12. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
Shi Y; Dong M; Hong X; Zhang W; Feng J; Zhu J; Yu L; Ke X; Huang H; Shen Z; Fan Y; Li W; Zhao X; Qi J; Huang H; Zhou D; Ning Z; Lu X
Ann Oncol; 2015 Aug; 26(8):1766-71. PubMed ID: 26105599
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 19 cases of subcutaneous panniculitis T-cell lymphoma with literature review].
Huang JJ; Cai MY; Ye S; Li ZM; Huang HQ; Lin TY
Ai Zheng; 2009 Oct; 28(10):1093-9. PubMed ID: 19799820
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma.
Wang J; Fang Y; Ma S; Su N; Zhang Y; Huang H; Li Z; Huang H; Tian X; Cai J; Xia Y; Liu P; Cai Q
Leuk Res; 2021 Dec; 111():106705. PubMed ID: 34534908
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma.
Rodriguez VR; Joshi A; Peng F; Rabah RM; Stockmann PT; Savaşan S
Pediatr Blood Cancer; 2009 Mar; 52(3):406-8. PubMed ID: 18985722
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous panniculitis-like T-cell cutaneous lymphoma.
Singh A; Kumar J; Kapur S; Ramesh V
Indian J Dermatol Venereol Leprol; 2008; 74(2):151-3. PubMed ID: 18388378
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.
Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F
Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721
[TBL] [Abstract][Full Text] [Related]
18. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment.
Merdin A; İskender D; Ulu BU; Doğan M; Çakar MK; Dal MS; Altuntaş F
Medicine (Baltimore); 2019 Jul; 98(30):e16482. PubMed ID: 31348254
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytosis Showing Complete Resolution With the BFM90 Protocol: Case Report and Review of Literature.
Singh S; Philip CC; John MJ
J Pediatr Hematol Oncol; 2019 Aug; 41(6):478-481. PubMed ID: 30730380
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Rojnuckarin P; Nakorn TN; Assanasen T; Wannakrairot P; Intragumtornchai T
Leuk Lymphoma; 2007 Mar; 48(3):560-3. PubMed ID: 17454599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
